Perfromance Wealth Partners, LLC Moderna, Inc. Transaction History

Perfromance Wealth Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$101.21 - $166.61 $202,420 - $333,220	2,000 New	2,000 $237,000
Q1 2023 Apr 20, 2023	SELL	$135.66 - $197.02 $149,361 - $216,919	-1,101 Reduced 42.18%	1,509 $231,000
Q4 2022 Jan 19, 2023	BUY	$118.38 - $210.04 $47,352 - $84,016	400 Added 18.1%	2,610 $0
Q3 2022 Oct 17, 2022	SELL	$118.07 - $194.18 $82,649 - $135,926	-700 Reduced 24.05%	2,210 $261,000
Q1 2022 Apr 21, 2022	BUY	$126.46 - $235.05 $151,752 - $282,060	1,200 Added 70.18%	2,910 $501,000
Q4 2021 Feb 03, 2022	BUY	$225.82 - $368.51 $386,152 - $630,152	1,710 New	1,710 $434,000

953

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Perfromance Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Perfromance Wealth Partners, LLC with notifications on news.